Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement

NOAF subsided 6 weeks after TAVR. AF prevalence and burden decreased significantly over time after SAVR, but remained stable after TAVR. These findings may be considered for post-procedural anti-coagulation strategy.